ALMBIH — Evidencija nestasice lijekova (Bosnia & Herzegovina) (ALMBIH)

ALMBIH — Evidencija nestasice lijekova (Bosnia & Herzegovina) is the official source of medicine shortage information for Bosnia and Herzegovina (Europe). Mederti checks its register daily and links every notice back to the original publication.

Official register

lijekovi.almbih.gov.ba

Country

Bosnia and Herzegovina

Notices tracked by Mederti

143

Last checked

2 Aug 2026

Latest notices from ALMBIH

• Liraglutide — active, medium, since 29 Jul 2026 (source)
• Indapamide-Hemihydrate — active, medium, since 27 Jul 2026 (source)
• Pentaeritritil Tetranitrat — active, medium, since 27 Jul 2026 (source)
• Pentaeritritil Tetranitrat — active, medium, since 24 Jul 2026 (source)
• Kapecitabin — active, medium, since 20 Jul 2026 (source)
• Hloropiramin — active, medium, since 9 Jul 2026 (source)
• Oksazepam — active, medium, since 9 Jul 2026 (source)
• Karboplatin — active, medium, since 9 Jul 2026 (source)
• Pemetreksed — active, medium, since 9 Jul 2026 (source)
• Natrijum-Valproat, Valproinska Kiselina — active, medium, since 8 Jul 2026 (source)
• Ibandronska Kiselina — active, medium, since 6 Jul 2026 (source)
• Indapamide-Hemihydrate — active, medium, since 6 Jul 2026 (source)
• Pankuronijum — active, medium, since 3 Jul 2026 (source)
• Hloropiramin — active, medium, since 27 Jun 2026 (source)
• Zolmitriptan — active, medium, since 19 Jun 2026 (source)

Mederti is not affiliated with or endorsed by ALMBIH — Evidencija nestasice lijekova (Bosnia & Herzegovina). All notices remain the property of their publisher and are linked to the original source.